Scientists Map Cancer-, Aging-Related Enzyme
Friday, April 12, 2013
Researchers have solved the puzzle of how the various components of an entire telomerase enzyme complex fit together and function in a three-dimensional structure.
Algeta Elects New Non-executive Members
Friday, April 12, 2013
Hilde Furberg and Paolo Pucci elected as new members of Algeta’s Board of Directors.
Aprea Presents Preclinical Data at AACR
Thursday, April 11, 2013
Strong synergistic effect with APR-246 and cisplatin.
BioLineRx Receives Regulatory Approval to Commence Phase II Clinical Trial for BL-8040
Thursday, April 11, 2013
Final results expected in H2 2014.
Early Results of Activartis AV0113 Cancer Immunotherapy in Glioblastoma Trial Reveal Promising Trend
Thursday, April 11, 2013
Glioblastoma multiforme (GBM) is the most severe form of brain cancer and progresses rapidly.
Affymetrix and BioDiscovery Announce Software for Analysis of Whole Genome Copy Number Data
Thursday, April 11, 2013
Generated from FFPE solid tumor samples for accelerating cancer translational research.
ARIAD Presents Data for Investigational Inhibitor
Thursday, April 11, 2013
New preclinical data showing AP26113 inhibits clinically relevant mutants of ALK and ROS1.
Engineered Small-Pox Vaccine may Kill Liver Cancer
Thursday, April 11, 2013
As part of a multicenter clinical trial, researchers at University of California are evaluating Pexa-Vec (JX-594) to slow the progression of hepatocellular carcinoma (HCC) or liver cancer.
Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant
Thursday, April 11, 2013
Inovio to advance painless device to simultaneously deliver multiple vaccines using electroporation technology.
|
|
|
|
|
|
